An updated overview of animal models in neuropsychiatry

Neuroscience - Tập 240 - Trang 204-218 - 2013
M. Razafsha1,2, H. Behforuzi3, H. Harati4, R.AL. Wafai5, A. Khaku3, S. Mondello6, M.S. Gold2, F.H. Kobeissy2
1Department of Psychiatry, Residency Program, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA
2Department of Psychiatry, Center for Neuroproteomics and Biomarkers Research, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA
3Department of Neurology, McKnight Brain Institute, University of Florida, Gainesville, FL 32610, USA
4Neurogenetics Program and Division of Pediatric Neurology, Departments of Pediatrics and Adolescent Medicine, and Biochemistry, American University of Beirut (AUBMC), Beirut 1107 2020, Lebanon
5American University of Beirut, Department of Biochemistry and Molecular Genetics, Beirut, Lebanon
6Center of Innovative Research Banyan Biomarkers Inc., Alachua, Fl, USA

Tài liệu tham khảo

Abi-Saab, 1998, The NMDA antagonist model for schizophrenia: promise and pitfalls, Pharmacopsychiatry, 31, 104, 10.1055/s-2007-979354 1999 Akbarian, 2005, Chromatin alterations associated with down-regulated metabolic gene expression in the prefrontal cortex of subjects with schizophrenia, Arch Gen Psychiatry, 62, 829, 10.1001/archpsyc.62.8.829 Amann LC, Gandal MJ, Halene TB, Ehrlichman RS, White SL, McCarren HS, Siegel SJ. Mouse behavioral endophenotypes for schizophrenia. Brain Res Bull, in press (Corrected Proof.2010). Arad, 2010, Sex-dependent antipsychotic capacity of 17beta-estradiol in the latent inhibition model: a typical antipsychotic drug in both sexes, atypical antipsychotic drug in males, Neuropsychopharmacology, 35, 2179, 10.1038/npp.2010.89 Azrin, 1967, A rat chamber and electrode procedure for avoidance conditioning, J Exp Anal Behav, 10, 291, 10.1901/jeab.1967.10-291 Baas, 2002, Benzodiazepines have no effect on fear-potentiated startle in humans, Psychopharmacology (Berl), 161, 233, 10.1007/s00213-002-1011-8 Baas, 2009, Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine, Psychopharmacology (Berl), 205, 73, 10.1007/s00213-009-1516-5 Babovic, 2007, Exploratory and habituation phenotype of heterozygous and homozygous COMT knockout mice, Behav Brain Res, 183, 236, 10.1016/j.bbr.2007.07.006 Barlow, 2000, Unraveling the mysteries of anxiety and its disorders from the perspective of emotion theory, Am Psychol, 55, 1247, 10.1037/0003-066X.55.11.1247 Beck, 1985 Belozertseva, 2007, Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests, Eur Neuropsychopharmacol, 17, 172, 10.1016/j.euroneuro.2006.03.002 Belzung, 1992, Hippocampal mossy fibres: implication in novelty reactions or in anxiety behaviours?, Behav Brain Res, 51, 149, 10.1016/S0166-4328(05)80208-6 Bijlsma, 2010, Fear-potentiated startle, but not light-enhanced startle, is enhanced by anxiogenic drugs, Pharmacol Biochem Behav, 96, 24, 10.1016/j.pbb.2010.04.002 Bills, 2005, Effects of metabotropic glutamate receptor 5 on latent inhibition in conditioned taste aversion, Behav Brain Res, 157, 71, 10.1016/j.bbr.2004.06.011 Bitsios, 1999, Comparison of the effects of diazepam on the fear-potentiated startle reflex and the fear-inhibited light reflex in man, J Psychopharmacol, 13, 226, 10.1177/026988119901300303 Borrelli, 2008, Decoding the epigenetic language of neuronal plasticity, Neuron, 60, 961, 10.1016/j.neuron.2008.10.012 Bowie, 2008, Predicting schizophrenia patients’ real-world behavior with specific neuropsychological and functional capacity measures, Biol Psychiatry, 63, 505, 10.1016/j.biopsych.2007.05.022 Boyadjieva, 2012, Epigenetics of psychoactive drugs, J Pharm Pharmacol, 64, 1349, 10.1111/j.2042-7158.2012.01475.x Braff, 2001, Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies, Psychopharmacology (Berl), 156, 234, 10.1007/s002130100810 Braff, 1995, Gating and habituation deficits in the schizophrenia disorders, Clin Neurosci, 3, 131 Breuer, 2009, Antidepressant effects of pramipexole, a dopamine D3/D2 receptor agonist, and 7-OH-DPAT, a dopamine D3 receptor agonist, in olfactory bulbectomized rats, Eur J Pharmacol, 616, 134, 10.1016/j.ejphar.2009.06.029 Breuer, 2007, Long-term behavioral changes after cessation of chronic antidepressant treatment in olfactory bulbectomized rats, Biol Psychiatry, 61, 990, 10.1016/j.biopsych.2006.08.032 Brodkin, 2002, Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone, Pharmacol Biochem Behav, 73, 359, 10.1016/S0091-3057(02)00828-6 Brown, 2002, Social roles, context and evolution in the origins of depression, J Health Social Behav, 43, 255, 10.2307/3090203 Buwalda, 2005, Long-term effects of social stress on brain and behavior: a focus on hippocampal functioning, Neurosci Biobehav Rev, 29, 83, 10.1016/j.neubiorev.2004.05.005 Caldji, 1998, Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat, Proc Natl Acad Sci U S A, 95, 5335, 10.1073/pnas.95.9.5335 Carter, 2011, Absence of preference for social novelty and increased grooming in integrin beta3 knockout mice: initial studies and future directions, Autism Res, 4, 57, 10.1002/aur.180 Chadman, 2009, Criteria for validating mouse models of psychiatric diseases, Am J Med Genet B Neuropsychiatry Genet, 150B, 1, 10.1002/ajmg.b.30777 Chang, 2007, Disruption of the US pre-exposure effect and latent inhibition in two-way active avoidance by systemic amphetamine in C57BL/6 mice, Psychopharmacology (Berl), 191, 211, 10.1007/s00213-006-0649-z Connor, 2008, Akbarian S (DNA methylation changes in schizophrenia and bipolar disorder, Epigenetics, 3, 55, 10.4161/epi.3.2.5938 Cook, 2006, Current concepts in validity and reliability for psychometric instruments: theory and application, Am J Med, 119, e167 Cronbach, 1955, Construct validity in psychological tests, Psychol Bull, 52, 281, 10.1037/h0040957 Cryan, 2005, The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice, Neurosci Biobehav Rev, 29, 571, 10.1016/j.neubiorev.2005.03.009 Davis, 1990, Animal models of anxiety based on classical conditioning: the conditioned emotional response (CER) and the fear-potentiated startle effect, Pharmacol Ther, 47, 147, 10.1016/0163-7258(90)90084-F Davis, 1990, Pharmacological and anatomical analysis of fear conditioning, NIDA Res Monogr, 97, 126 Davis, 2001, Fear-potentiated startle in rats, Curr Protoc Neurosci, 10.1002/0471142301.ns0811as14 Davis, 1993, Fear-potentiated startle: a neural and pharmacological analysis, Behav Brain Res, 58, 175, 10.1016/0166-4328(93)90102-V Desbonnet, 2009, Mutant models for genes associated with schizophrenia, Biochem Soc Trans, 37, 308, 10.1042/BST0370308 Deussing, 2006, Animal models of depression, Drug Discov Today Dis Models, 3, 375, 10.1016/j.ddmod.2006.11.003 Ding, 2009, Expression of RGS4 splice variants in dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients, Biol Psychiatry, 65, 541, 10.1016/j.biopsych.2008.10.026 Dominguez-Lopez, 2012, Characterization of serotonin neurotransmission in knockout mice: implications for major depression, Rev Neurosci, 23, 429, 10.1515/revneuro-2012-0044 Dong, 2005, Reelin and glutamic acid decarboxylase67 promoter remodeling in an epigenetic methionine-induced mouse model of schizophrenia, Proc Natl Acad Sci U S A, 102, 12578, 10.1073/pnas.0505394102 Duffy, 2008, d-Serine augments NMDA-NR2B receptor-dependent hippocampal long-term depression and spatial reversal learning, Neuropsychopharmacology, 33, 1004, 10.1038/sj.npp.1301486 Dulawa, 1999, Dopamine D4 receptor-knock-out mice exhibit reduced exploration of novel stimuli, J Neurosci, 19, 9550, 10.1523/JNEUROSCI.19-21-09550.1999 Duman, 2006, A neurotrophic model for stress-related mood disorders, Biol Psychiatry, 59, 1116, 10.1016/j.biopsych.2006.02.013 Ellenbroek, 1990, Animal models with construct validity for schizophrenia, Behav Pharmacol, 1, 469, 10.1097/00008877-199000160-00001 Eren Kocak, 2012, Psychiatric disorders and epigenetics, Turk Psikiyatri Derg, 23, 130 Evertts, 2010, Modern approaches for investigating epigenetic signaling pathways, J Appl Physiol, 109, 927, 10.1152/japplphysiol.00007.2010 Feifel, 2009, Prepulse inhibition of startle in adults with ADHD, J Psychiatr Res, 43, 484, 10.1016/j.jpsychires.2008.06.004 Feng, 2009, The role of DNA methylation in the central nervous system and neuropsychiatric disorders, Int Rev Neurobiol, 89, 67, 10.1016/S0074-7742(09)89004-1 Fernandes, 2006, Performance deficit of alpha7 nicotinic receptor knockout mice in a delayed matching-to-place task suggests a mild impairment of working/episodic-like memory, Genes Brain Behav, 5, 433, 10.1111/j.1601-183X.2005.00176.x Fernando, 2011, Animal models of neuropsychiatric disorders, Annu Rev Clin Psychol, 7, 39, 10.1146/annurev-clinpsy-032210-104454 File, 2003, A review of 25years of the social interaction test, Eur J Pharmacol, 463, 35, 10.1016/S0014-2999(03)01273-1 Flint, 2008, Animal models of psychiatric disease, Curr Opin Genet Dev, 18, 235, 10.1016/j.gde.2008.07.002 Foa, 1992, Uncontrollability and unpredictability in post-traumatic stress disorder: an animal model, Psychol Bull, 112, 218, 10.1037/0033-2909.112.2.218 Francis, 1999, Nongenomic transmission across generations of maternal behavior and stress responses in the rat, Science, 286, 1155, 10.1126/science.286.5442.1155 Fukui, 2007, Vmat2 heterozygous mutant mice display a depressive-like phenotype, J Neurosci, 27, 10520, 10.1523/JNEUROSCI.4388-06.2007 Gardier, 2009, Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review, Fundam Clin Pharmacol, 23, 23, 10.1111/j.1472-8206.2008.00640.x Geyer, 2008, Developing translational animal models for symptoms of schizophrenia or bipolar mania, Neurotox Res, 14, 71, 10.1007/BF03033576 Geyer, 2000, Animal Models of Psychiatric Disorders Geyer, 2002, Mouse genetic models for prepulse inhibition: an early review, Mol Psychiatry, 7, 1039, 10.1038/sj.mp.4001159 Geyer, 1986, Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses, Pharmacol Biochem Behav, 25, 277, 10.1016/0091-3057(86)90266-2 Gleason, 2007, A parametric analysis of punishment frequency as a determinant of the response to chlordiazepoxide in the Vogel conflict test in rats, Pharmacol Biochem Behav, 87, 380, 10.1016/j.pbb.2007.05.011 Gould TD, Dao DT, Kovacsics CE (2009) The Open Field Test. In: Gould TD, editor. Mood and Anxiety Related Phenotypes in Mice: Characterization Using Behavioral Tests, Vol. 42, pp. 1–20. Graham, 2005, Effects of lorazepam on fear-potentiated startle responses in man, J Psychopharmacol, 19, 249, 10.1177/0269881105051528 Gray, 1995, The role of mesolimbic dopaminergic and retrohippocampal afferents to the nucleus accumbens in latent inhibition: implications for schizophrenia, Behav Brain Res, 71, 19, 10.1016/0166-4328(95)00154-9 Grayson, 2009, From trans-methylation to cytosine methylation: evolution of the methylation hypothesis of schizophrenia, Epigenetics, 4, 144, 10.4161/epi.4.3.8534 Grillon, 2006, The benzodiazepine alprazolam dissociates contextual fear from cued fear in humans as assessed by fear-potentiated startle, Biol Psychiatry, 60, 760, 10.1016/j.biopsych.2005.11.027 Guidotti, 2000, Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study, Arch Gen Psychiatry, 57, 1061, 10.1001/archpsyc.57.11.1061 Hall, 1934, Emotional behavior in the rat. I. Defecation and urination as measures of individual differences in emotionality, J Comp Psychol, 18, 9, 10.1037/h0071444 Hammack, 2012, Overlapping neurobiology of learned helplessness and conditioned defeat: implications for PTSD and mood disorders, Neuropharmacology, 62, 565, 10.1016/j.neuropharm.2011.02.024 Hashimoto, 2008, Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia, Mol Psychiatry, 13, 147, 10.1038/sj.mp.4002011 Henry, 2011, Translational methamphetamine ARCG (Effect of methamphetamine dependence on inhibitory deficits in a novel human open-field paradigm), Psychopharmacology (Berl), 215, 697, 10.1007/s00213-011-2170-2 Holmes, 2002, Evaluation of antidepressant-related behavioral responses in mice lacking the serotonin transporter, Neuropsychopharmacology, 27, 914, 10.1016/S0893-133X(02)00374-3 Horwood, 2004, Evidence for disrupted NMDA receptor function in tissue plasminogen activator knockout mice, Behav Brain Res, 150, 127, 10.1016/S0166-4328(03)00248-1 Insel, 2007, From animal models to model animals, Biol Psychiatry, 62, 1337, 10.1016/j.biopsych.2007.10.001 Jarosik, 2007, Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy, Exp Neurol, 204, 20, 10.1016/j.expneurol.2006.09.008 Jaworski, 2005, Prepulse inhibition and fear-potentiated startle are altered in tissue inhibitor of metalloproteinase-2 (TIMP-2) knockout mice, Brain Res, 1051, 81, 10.1016/j.brainres.2005.05.057 Jiang, 2008, Epigenetics in the nervous system, J Neurosci, 28, 11753, 10.1523/JNEUROSCI.3797-08.2008 Joober, 2002, Genetics of schizophrenia: from animal models to clinical studies, J Psychiatry Neurosci, 27, 336 Joseph, 1993, Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure, Psychopharmacology (Berl), 110, 187, 10.1007/BF02246971 Jovanovic, 2010, Impaired fear inhibition is a biomarker of PTSD but not depression, Depress Anxiety, 27, 244, 10.1002/da.20663 Jovanovic, 2010, Fear potentiation is associated with hypothalamic–pituitary–adrenal axis function in PTSD, Psychoneuroendocrinology, 35, 846, 10.1016/j.psyneuen.2009.11.009 Kalueff, 2004, Experimental modeling of anxiety and depression, Acta Neurobiol Exp (Wars), 64, 439 Karoutzou, 2008, The myelin-pathogenesis puzzle in schizophrenia: a literature review, Mol Psychiatry, 13, 245, 10.1038/sj.mp.4002096 Kawa, 2012, A brief historicity of the Diagnostic and Statistical Manual of Mental Disorders: issues and implications for the future of psychiatric canon and practice, Philos Ethics Humanit Med, 7, 2, 10.1186/1747-5341-7-2 Keefe, 2007, Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial, Arch Gen Psychiatry, 64, 633, 10.1001/archpsyc.64.6.633 Kelly, 1997, The olfactory bulbectomized rat as a model of depression: an update, Pharmacol Ther, 74, 299, 10.1016/S0163-7258(97)00004-1 Kendler, 2002, Toward a comprehensive developmental model for major depression in women, Am J Psychiatry, 159, 1133, 10.1176/appi.ajp.159.7.1133 Kendler, 1999, The assessment of dependence in the study of stressful life events: validation using a twin design, Psychol Med, 29, 1455, 10.1017/S0033291798008198 Kendler, 1999, Causal relationship between stressful life events and the onset of major depression, Am J Psychiatry, 156, 837, 10.1176/ajp.156.6.837 Keshavan, 2011, Schizophrenia, “Just the Facts” 6. Moving ahead with the schizophrenia concept: from the elephant to the mouse, Schizophr Res, 127, 3, 10.1016/j.schres.2011.01.011 Kim, 2006, Histone deacetylase inhibitors for cancer therapy, Epigenetics, 1, 14, 10.4161/epi.1.1.2644 Kluge, 2011, Translating potential biomarker candidates for schizophrenia and depression to animal models of psychiatric disorders, Expert Rev Mol Diagn, 11, 721, 10.1586/erm.11.61 Knoll, 2007, Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats, J Pharmacol Exp Ther, 323, 838, 10.1124/jpet.107.127415 Konradi, 2004, Molecular evidence for mitochondrial dysfunction in bipolar disorder, Arch Gen Psychiatry, 61, 300, 10.1001/archpsyc.61.3.300 Kudryavtseva, 1991, Social model of depression in mice of C57BL/6J strain, Pharmacol Biochem Behav, 38, 315, 10.1016/0091-3057(91)90284-9 Kulkarni, 2007, Elevated zero maze: a paradigm to evaluate antianxiety effects of drugs, Methods Find Exp Clin Pharmacol, 29, 343, 10.1358/mf.2007.29.5.1117557 Kumari, 1999, Effects of d-amphetamine and haloperidol on latent inhibition in healthy male volunteers, J Psychopharmacol, 13, 398, 10.1177/026988119901300411 Kundakovic, 2009, The reelin and GAD67 promoters are activated by epigenetic drugs that facilitate the disruption of local repressor complexes, Mol Pharmacol, 75, 342, 10.1124/mol.108.051763 LaFollette, 1993, Animal models in biomedical research: some epistemological worries, Public Aff Q, 7, 113 Landis, 1939 Laurent, 2010, Role of the basolateral amygdala in the reinstatement and extinction of fear responses to a previously extinguished conditioned stimulus, Learn Membr, 17, 86, 10.1101/lm.1655010 LeDoux, 1988, Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear, J Neurosci, 8, 2517, 10.1523/JNEUROSCI.08-07-02517.1988 Levenson, 2008, The role of reelin in adult synaptic function and the genetic and epigenetic regulation of the reelin gene, Biochim Biophys Acta, 8, 422, 10.1016/j.bbagrm.2008.01.001 Li, 2009, Top–down modulation of prepulse inhibition of the startle reflex in humans and rats, Neurosci Biobehav Rev, 33, 1157, 10.1016/j.neubiorev.2009.02.001 Lister, 1990, Ethologically-based animal models of anxiety disorders, Pharmacol Ther, 46, 321, 10.1016/0163-7258(90)90021-S Liu, 1997, Maternal care, hippocampal glucocorticoid receptors, and hypothalamic–pituitary–adrenal responses to stress, Science, 277, 1659, 10.1126/science.277.5332.1659 LoLordo, 2001, Learned helplessness and depression, 63 Lubow, 1997, Latent inhibition as a measure of learned inattention: some problems and solutions, Behav Brain Res, 88, 75, 10.1016/S0166-4328(97)02307-3 Lubow, 2005, Construct validity of the animal latent inhibition model of selective attention deficits in schizophrenia, Schizophr Bull, 31, 139, 10.1093/schbul/sbi005 Lyons, 2009, Animal models Maier, 1984, Learned helplessness and animal models of depression, Prog Neuropsychopharmacol Biol Psychiatry, 8, 435, 10.1016/S0278-5846(84)80032-9 Maier, 2001, Exposure to the stressor environment prevents the temporal dissipation of behavioral depression/learned helplessness, Biol Psychiatry, 49, 763, 10.1016/S0006-3223(00)01095-7 Maier, 1976, Learned helplessness: theory and evidence, J Exp Psychol, 105, 103, 10.1037/0096-3445.105.1.3 Margueron, 2005, The key to development: interpreting the histone code?, Curr Opin Genet Dev, 15, 163, 10.1016/j.gde.2005.01.005 Maric, 2012, Why schizophrenia genetics needs epigenetics: a review, Psychiatr Danub, 24, 2 McGowan, 2009, Epigenetic regulation of the glucocorticoid receptor in human brain associates with childhood abuse, Nat Neurosci, 12, 342, 10.1038/nn.2270 McKinney, 2001, Overview of the past contributions of animal models and their changing place in psychiatry, Semin Clin Neuropsychiatry, 6, 68, 10.1053/scnp.2001.20292 Meincke, 2004, Sensitization and habituation of the acoustic startle reflex in patients with schizophrenia, Psychiatry Res, 126, 51, 10.1016/j.psychres.2004.01.003 Mill, 2008, Epigenomic profiling reveals DNA-methylation changes associated with major psychosis, Am J Hum Genet, 82, 696, 10.1016/j.ajhg.2008.01.008 Millan, 2003, The Vogel conflict test: procedural aspects, gamma-aminobutyric acid, glutamate and monoamines, Eur J Pharmacol, 463, 67, 10.1016/S0014-2999(03)01275-5 Miyakawa, 2003, Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia, Proc Natl Acad Sci U S A, 100, 8987, 10.1073/pnas.1432926100 Nestler, 2010, Animal models of neuropsychiatric disorders, Nat Neurosci, 13, 1161, 10.1038/nn.2647 Noh, 2005, DNA methyltransferase 1 regulates reelin mRNA expression in mouse primary cortical cultures, Proc Natl Acad Sci U S A, 102, 1749, 10.1073/pnas.0409648102 Norton, 2006, An update on the genetics of schizophrenia, Curr Opin Psychiatry, 19, 158, 10.1097/01.yco.0000214341.52249.59 O’Tuathaigh, 2007, Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour, Neurosci Biobehav Rev, 31, 60, 10.1016/j.neubiorev.2006.04.002 O’Tuathaigh, 2010, Mutant mouse models: genotype–phenotype relationships to negative symptoms in schizophrenia, Schizophr Bull, 36, 271, 10.1093/schbul/sbp125 Pae, 2007, Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder, Am J Med Genet B Neuropsychiatr Genet, 144B, 701, 10.1002/ajmg.b.30439 Palanza, 2001, Social stress in mice: gender differences and effects of estrous cycle and social dominance, Physiol Behav, 73, 411, 10.1016/S0031-9384(01)00494-2 Paterlini, 2005, Transcriptional and behavioral interaction between 22q11.2 orthologs modulates schizophrenia-related phenotypes in mice, Nat Neurosci, 8, 1586, 10.1038/nn1562 Pattij, 2004, Impulsive-like behavior in differential-reinforcement-of-low-rate 36 s responding in mice depends on training history, Neurosci Lett, 354, 169, 10.1016/j.neulet.2003.10.004 Peleg-Raibstein, 2008, Amphetamine sensitization in rats as an animal model of schizophrenia, Behav Brain Res, 191, 190, 10.1016/j.bbr.2008.03.037 Phillips, 1992, Differential contribution of amygdala and hippocampus to cued and contextual fear conditioning, Behav Neurosci, 106, 274, 10.1037/0735-7044.106.2.274 Pomierny-Chamiolo, 2010, NMDA but not AMPA glutamatergic receptors are involved in the antidepressant-like activity of MTEP during the forced swim test in mice, Pharmacol Rep, 62, 1186, 10.1016/S1734-1140(10)70381-9 Porsolt, 1977, Behavioral despair in mice: a primary screening test for antidepressants, Arch Int Pharmacodyn Ther, 229, 327 Probst, 2009, Epigenetic inheritance during the cell cycle, Nat Rev Mol Cell Biol, 10, 192, 10.1038/nrm2640 Ptak, 2010, Epigenetic approaches to psychiatric disorders, Dialogues Clin Neurosci, 12, 25, 10.31887/DCNS.2010.12.1/cptak Raybould, 2005, Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1), Biol Psychiatry, 57, 696, 10.1016/j.biopsych.2005.01.018 Reichenberg, 2009, Epigenetics, genomic mutations and cognitive function, Cogn Neuropsychiatry, 14, 377, 10.1080/13546800902978417 Riba, 2001, Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose–response study, Psychopharmacology (Berl), 157, 358, 10.1007/s002130100816 Risbrough, 2005, Anxiogenic treatments do not increase fear-potentiated startle in mice, Biol Psychiatry, 57, 33, 10.1016/j.biopsych.2004.10.006 Rupniak, 2003, Animal models of depression: challenges from a drug development perspective, Behav Pharmacol, 14, 385 Sananbenesi, 2009, The epigenetic bottleneck of neurodegenerative and psychiatric diseases, Biol Chem, 390, 1145, 10.1515/BC.2009.131 Sankoorikal, 2006, A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains, Biol Psychiatry, 59, 415, 10.1016/j.biopsych.2005.07.026 Savignac, 2011, Resistance to early-life stress in mice: effects of genetic background and stress duration, Front Behav Neurosci, 5, 13, 10.3389/fnbeh.2011.00013 Schmidt, 2010, A novel chronic social stress paradigm in female mice, Horm Behav, 57, 415, 10.1016/j.yhbeh.2010.01.010 Seligman, 1975, Learned helplessness in the rat: time course, immunization, and reversibility, J Comp Physiol Psychol, 88, 542, 10.1037/h0076431 Shekhar, 2001, Summary of a National Institute of Mental Health workshop: developing animal models of anxiety disorders, Psychopharmacology (Berl), 157, 327, 10.1007/s002130100859 Shively, 2005, Social stress-associated depression in adult female cynomolgus monkeys (Macaca fascicularis), Biol Psychol, 69, 67, 10.1016/j.biopsycho.2004.11.006 Sokolov, 2007, Oligodendroglial abnormalities in schizophrenia, mood disorders and substance abuse. Comorbidity, shared traits, or molecular phenocopies?, Int J Neuropsychopharmacol, 10, 547, 10.1017/S1461145706007322 Song, 2005, The olfactory bulbectomised rat as a model of depression, Neurosci Biobehav Rev, 29, 627, 10.1016/j.neubiorev.2005.03.010 Spencer, 2005, Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome, Genes Brain Behav, 4, 420, 10.1111/j.1601-183X.2005.00123.x Steele, 1999, Delay-dependent impairment of a matching-to-place task with chronic and intrahippocampal infusion of the NMDA-antagonist D-AP5, Hippocampus, 9, 118, 10.1002/(SICI)1098-1063(1999)9:2<118::AID-HIPO4>3.0.CO;2-8 Stefansson, 2002, Neuregulin 1 and susceptibility to schizophrenia, Am J Hum Genet, 71, 877, 10.1086/342734 Steimer, 2002, The biology of fear- and anxiety-related behaviors, Dialogues Clin Neurosci, 4, 231, 10.31887/DCNS.2002.4.3/tsteimer Steimer, 2011, Animal models of anxiety disorders in rats and mice: some conceptual issues, Dialogues Clin Neurosci, 13, 495, 10.31887/DCNS.2011.13.4/tsteimer Steru, 1985, The tail suspension test: a new method for screening antidepressants in mice, Psychopharmacology (Berl), 85, 367, 10.1007/BF00428203 Straub, 2002, Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia, Am J Hum Genet, 71, 337, 10.1086/341750 Swerdlow, 2008, Realistic expectations of prepulse inhibition in translational models for schizophrenia research, Psychopharmacology (Berl), 199, 331, 10.1007/s00213-008-1072-4 Tandon, 2011, Antipsychotics in the treatment of schizophrenia: an overview, J Clin Psychiatry, 72, 4 Tandon, 2009, Schizophrenia, “just the facts” 4. Clinical features and conceptualization, Schizophr Res, 110, 1, 10.1016/j.schres.2009.03.005 Thiagalingam, 2003, Histone deacetylases: unique players in shaping the epigenetic histone code, Ann N Y Acad Sci, 983, 84, 10.1111/j.1749-6632.2003.tb05964.x Treit, 1990, A comparison of anxiolytic and nonanxiolytic agents in the shock-probe/burying test for anxiolytics, Pharmacol Biochem Behav, 36, 203, 10.1016/0091-3057(90)90151-7 Tremolizzo, 2002, An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability, Proc Natl Acad Sci U S A, 99, 17095, 10.1073/pnas.262658999 Tremolizzo, 2005, Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice, Biol Psychiatry, 57, 500, 10.1016/j.biopsych.2004.11.046 Tsang, 2010, Review on vocational predictors: a systematic review of predictors of vocational outcomes among individuals with schizophrenia: an update since 1998, Aust N Z J Psychiatry, 44, 495 Tsankova, 2006, Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action, Nat Neurosci, 9, 519, 10.1038/nn1659 van Riezen, 1990, Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomized rats, Pharmacol Ther, 47, 21, 10.1016/0163-7258(90)90043-2 Venzala, 2012, Chronic social defeat stress model: behavioral features, antidepressant action, and interaction with biological risk factors, Psychopharmacology (Berl), 224, 313, 10.1007/s00213-012-2754-5 Walker, 2002, The role of amygdala glutamate receptors in fear learning, fear-potentiated startle, and extinction, Pharmacol Biochem Behav, 71, 379, 10.1016/S0091-3057(01)00698-0 Watanabe, 2007, Fabp7 maps to a quantitative trait locus for a schizophrenia endophenotype, PLoS Biol, 5, e297, 10.1371/journal.pbio.0050297 Weaver, 2004, Epigenetic programming by maternal behavior, Nat Neurosci, 7, 847, 10.1038/nn1276 Weaver, 2005, Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: altering epigenetic marking later in life, J Neurosci, 25, 11045, 10.1523/JNEUROSCI.3652-05.2005 Weiss, 1985, Neurochemical basis of stress-induced depression, Psychopharmacol Bull, 21, 447 Willner, 1990, Animal models of depression: an overview, Pharmacol Therapeut, 45, 425, 10.1016/0163-7258(90)90076-E Yeomans, 2002, Tactile, acoustic and vestibular systems sum to elicit the startle reflex, Neurosci Biobehav Rev, 26, 1, 10.1016/S0149-7634(01)00057-4 Young, 2007, A reverse-translational approach to bipolar disorder: rodent and human studies in the Behavioral Pattern Monitor, Neurosci Biobehav Rev, 31, 882, 10.1016/j.neubiorev.2007.05.009 Young, 2009, Using the MATRICS to guide development of a preclinical cognitive test battery for research in schizophrenia, Pharmacol Ther, 122, 150, 10.1016/j.pharmthera.2009.02.004